CHO-K1 Cells (suspension adapted)
General information
| Description | CHO-K1 cells are a subline derived from the CHO cell line, which was originally established in the early 1950s from a Chinese hamster ovary. CHO-K1 cells are widely utilized in the production of therapeutic monoclonal antibodies and other biopharmaceuticals. Their extensive use in biopharmaceutical protein production and vaccines is attributed to their eukaryotic nature, which allows for proper folding, assembly, and post-translational modifications such as glycosylation, which influences the stability, efficacy, and safety of the produced proteins. In the realm of recombinant protein production, the CHO-K1 cell line is used to express a wide array of proteins, including monoclonal antibodies, growth factors, cytokines, and enzymes. These proteins have applications in therapeutic treatments, diagnostic assays, and vaccine formulations. CHO-K1 cells exhibit a robust growth rate and are adaptable to various culture conditions, including suspension and adherent cultures, making them highly valuable for large-scale bioproduction processes. They possess a high level of genetic stability and are used for stable cell line development as they are capable of amplifying and expressing exogenous genes efficiently, which is critical for producing high yields of recombinant proteins. CHO-K1 chinese hamster cells can be easily transfected with a variety of vectors for gene expression, facillitating gene editing or knockdown. This flexibility allows researchers to introduce specific genes, silence genes, or even perform targeted gene editing using technologies like CRISPR-Cas9 in CHO-K1 host cells. In conclusion, the chinese hamster CHO-K1 cells and CHO cells are pivotal in biotechnological research and biopharmaceutical production, offering a versatile platform for the study of gene function and the large-scale production of recombinant proteins. |
|---|---|
| Organism | Chinese hamster |
| Tissue | Ovary |
| Applications | This cell line is an optimal choice for toxicology, industrial biotechnology and bioproduction. |
| Synonyms | CHO K1, CHOK1, CHO cell clone K1, GM15452 |
Characteristics
| Age | Adult |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Growth properties | Suspension |
Regulatory Data
| Citation | CHO-K1 suspension adapted (Cytion catalog number 603486) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10029 |
| CellosaurusAccession | CVCL_0214 |
Biomolecular Data
| Virus susceptibility | Vesicular stomatitis (Indiana), Getah virus Virus Resist: poliovirus 2, modoc virus, Button Willow virus |
|---|---|
| Reverse transcriptase | Negative |
| Karyotype | Chromosome Frequency Distribution 50 Cells: 2n = 22. Stemline number is hypodiploid |
Handling
| Culture Medium | CD CHO ThermoFisher, serum free ready to use. |
|---|---|
| Supplements | L-glutamine: add to a final 8 mM (typically 40 mL per liter of a 200 mM stock) before use. This is mandatory for CD CHO. Add anti-clumping agent 1:100 and HT supplement 1:100 to the cell suspension. |
| Dissociation Reagent | None |
| Doubling time | 22 hours |
| Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Seeding density | 4 x 105 cells/ml |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. Cells must be cultivated on an orbital shaker in baffled Erlenmeyer shake flasks at 110 rpm. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 603486-160126 | Certificate of Analysis | 26. Mar. 2026 | 603480 |
Material Transfer Agreement
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.